Phreesia, Inc. (NYSE: PHR) Stock Competitors & Peer Comparison
See PHR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHR | $10.10 | +0.60% | 620M | 35.82 | $0.28 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $77.10 | -0.95% | 13.7B | -156.06 | -$0.50 | N/A |
| BTSG | $56.77 | -0.02% | 11B | 38.00 | $1.47 | N/A |
| BTSGU | $187.90 | -0.25% | 10.9B | 125.71 | $1.47 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $92.12 | -3.17% | 7.9B | 22.08 | $4.28 | N/A |
| HNGE | $94.34 | -0.59% | 7.3B | 50.51 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $26.71 | +2.28% | 5B | 17.54 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
PHR vs GEHCV Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas GEHCV's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, PHR is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
PHR vs TEM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, TEM has a market cap of 13.7B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while TEM trades at $77.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas TEM's P/E ratio is -156.06. In terms of profitability, PHR's ROE is +0.03%, compared to TEM's ROE of -0.55%. Regarding short-term risk, PHR is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for PHR.Check TEM's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
PHR vs BTSG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, BTSG has a market cap of 11B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while BTSG trades at $56.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas BTSG's P/E ratio is 38.00. In terms of profitability, PHR's ROE is +0.03%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, PHR is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
PHR vs BTSGU Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, BTSGU has a market cap of 10.9B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while BTSGU trades at $187.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas BTSGU's P/E ratio is 125.71. In terms of profitability, PHR's ROE is +0.03%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, PHR is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
PHR vs SGFY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SGFY's P/E ratio is 70.91. In terms of profitability, PHR's ROE is +0.03%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, PHR is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
PHR vs HQY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while HQY trades at $92.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas HQY's P/E ratio is 22.08. In terms of profitability, PHR's ROE is +0.03%, compared to HQY's ROE of +0.11%. Regarding short-term risk, PHR is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for PHR.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
PHR vs HNGE Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, HNGE has a market cap of 7.3B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while HNGE trades at $94.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas HNGE's P/E ratio is 50.51. In terms of profitability, PHR's ROE is +0.03%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, PHR is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
PHR vs RCM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas RCM's P/E ratio is -102.21. In terms of profitability, PHR's ROE is +0.03%, compared to RCM's ROE of +0.00%. Regarding short-term risk, PHR is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
PHR vs DOCS Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while DOCS trades at $26.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas DOCS's P/E ratio is 17.54. In terms of profitability, PHR's ROE is +0.03%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, PHR is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for PHR.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
PHR vs WAY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, WAY has a market cap of 4.9B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while WAY trades at $25.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas WAY's P/E ratio is 17.03. In terms of profitability, PHR's ROE is +0.03%, compared to WAY's ROE of +0.04%. Regarding short-term risk, PHR is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
PHR vs HTFL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while HTFL trades at $49.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas HTFL's P/E ratio is -25.04. In terms of profitability, PHR's ROE is +0.03%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, PHR is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for PHR.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
PHR vs ONEM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ONEM's P/E ratio is -7.77. In terms of profitability, PHR's ROE is +0.03%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, PHR is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
PHR vs PRVA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, PRVA has a market cap of 2.5B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while PRVA trades at $19.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas PRVA's P/E ratio is 93.05. In terms of profitability, PHR's ROE is +0.03%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, PHR is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
PHR vs NXGN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas NXGN's P/E ratio is -266.00. In terms of profitability, PHR's ROE is +0.03%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, PHR is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for PHR.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
PHR vs OMCL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while OMCL trades at $33.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas OMCL's P/E ratio is 16.98. In terms of profitability, PHR's ROE is +0.03%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OMCL's competition here
Agiliti, Inc. (NYSE: AGTI)
PHR vs AGTI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas AGTI's P/E ratio is -71.79. In terms of profitability, PHR's ROE is +0.03%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, PHR is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
PHR vs CERT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CERT trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CERT's P/E ratio is 21.30. In terms of profitability, PHR's ROE is +0.03%, compared to CERT's ROE of -0.07%. Regarding short-term risk, PHR is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CERT's competition here
Omada Health (NASDAQ: OMDA)
PHR vs OMDA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while OMDA trades at $21.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas OMDA's P/E ratio is 294.43. In terms of profitability, PHR's ROE is +0.03%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, PHR is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for PHR.Check OMDA's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
PHR vs GDRX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while GDRX trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas GDRX's P/E ratio is 10.59. In terms of profitability, PHR's ROE is +0.03%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
PHR vs TDOC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, TDOC has a market cap of 1.1B. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while TDOC trades at $6.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas TDOC's P/E ratio is -6.34. In terms of profitability, PHR's ROE is +0.03%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, PHR is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
PHR vs CCLDO Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CCLDO's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
PHR vs HSTM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, HSTM has a market cap of 849.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while HSTM trades at $29.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas HSTM's P/E ratio is 40.39. In terms of profitability, PHR's ROE is +0.03%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, PHR is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HSTM's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
PHR vs SOPH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SOPH has a market cap of 691.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SOPH trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SOPH's P/E ratio is -7.42. In terms of profitability, PHR's ROE is +0.03%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, PHR is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
PHR vs MPLN-WT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, PHR is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
PHR vs ACCD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ACCD's P/E ratio is -3.08. In terms of profitability, PHR's ROE is +0.03%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, PHR is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ACCD's competition here
Claritev Corporation (NYSE: CTEV)
PHR vs CTEV Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CTEV has a market cap of 536.2M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CTEV trades at $29.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CTEV's P/E ratio is -1.85. In terms of profitability, PHR's ROE is +0.03%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, PHR is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CTEV's competition here
Sharecare, Inc. (NASDAQ: SHCR)
PHR vs SHCR Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SHCR's P/E ratio is -3.76. In terms of profitability, PHR's ROE is +0.03%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, PHR is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
PHR vs NRC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, NRC has a market cap of 479.4M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while NRC trades at $21.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas NRC's P/E ratio is 25.94. In terms of profitability, PHR's ROE is +0.03%, compared to NRC's ROE of +0.48%. Regarding short-term risk, PHR is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check NRC's competition here
Carlsmed, Inc. (NASDAQ: CARL)
PHR vs CARL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CARL has a market cap of 424.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CARL trades at $15.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CARL's P/E ratio is -10.91. In terms of profitability, PHR's ROE is +0.03%, compared to CARL's ROE of -0.38%. Regarding short-term risk, PHR is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CARL's competition here
Evolent Health, Inc. (NYSE: EVH)
PHR vs EVH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, EVH has a market cap of 415.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while EVH trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas EVH's P/E ratio is 28.42. In terms of profitability, PHR's ROE is +0.03%, compared to EVH's ROE of -0.99%. Regarding short-term risk, PHR is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for PHR.Check EVH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
PHR vs SLGCW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, PHR's ROE is +0.03%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, PHR is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
PHR vs SLGC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SLGC's P/E ratio is -3.04. In terms of profitability, PHR's ROE is +0.03%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, PHR is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
PHR vs TBRG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas TBRG's P/E ratio is 9.37. In terms of profitability, PHR's ROE is +0.03%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, PHR is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
PHR vs MPLN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MPLN's P/E ratio is -0.23. In terms of profitability, PHR's ROE is +0.03%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, PHR is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
PHR vs SY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SY has a market cap of 359.5M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SY trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SY's P/E ratio is -8.30. In terms of profitability, PHR's ROE is +0.03%, compared to SY's ROE of -0.16%. Regarding short-term risk, PHR is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
PHR vs TRHC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas TRHC's P/E ratio is -4.27. In terms of profitability, PHR's ROE is +0.03%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, PHR is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
PHR vs SMFR Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SMFR's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SMFR's competition here
American Well Corporation (NYSE: AMWL)
PHR vs AMWL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, AMWL has a market cap of 230M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while AMWL trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas AMWL's P/E ratio is -3.06. In terms of profitability, PHR's ROE is +0.03%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, PHR is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for PHR.Check AMWL's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
PHR vs SPOK Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SPOK has a market cap of 217.9M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SPOK trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SPOK's P/E ratio is 17.38. In terms of profitability, PHR's ROE is +0.03%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, PHR is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SPOK's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
PHR vs LFMDP Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, LFMDP has a market cap of 157.4M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while LFMDP trades at $23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas LFMDP's P/E ratio is -711.56. In terms of profitability, PHR's ROE is +0.03%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, PHR is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
PHR vs LFMD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, LFMD has a market cap of 156M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while LFMD trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas LFMD's P/E ratio is -6.45. In terms of profitability, PHR's ROE is +0.03%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, PHR is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for PHR.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
PHR vs OPRX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, OPRX has a market cap of 141.9M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while OPRX trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas OPRX's P/E ratio is 6.94. In terms of profitability, PHR's ROE is +0.03%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, PHR is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check OPRX's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
PHR vs HCAT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, HCAT has a market cap of 133.7M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while HCAT trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas HCAT's P/E ratio is 9.05. In terms of profitability, PHR's ROE is +0.03%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, PHR is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
PHR vs CPSI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CPSI's P/E ratio is -183.80. In terms of profitability, PHR's ROE is +0.03%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, PHR is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CPSI's competition here
Augmedix, Inc. (NASDAQ: AUGX)
PHR vs AUGX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas AUGX's P/E ratio is -4.99. In terms of profitability, PHR's ROE is +0.03%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, PHR is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AUGX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
PHR vs DH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, DH has a market cap of 95M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while DH trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas DH's P/E ratio is 3.46. In terms of profitability, PHR's ROE is +0.03%, compared to DH's ROE of -0.79%. Regarding short-term risk, PHR is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLD)
PHR vs CCLD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CCLD has a market cap of 91.4M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CCLD trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CCLD's P/E ratio is 8.27. In terms of profitability, PHR's ROE is +0.03%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
PHR vs WORX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas WORX's P/E ratio is -6.40. In terms of profitability, PHR's ROE is +0.03%, compared to WORX's ROE of -0.35%. Regarding short-term risk, PHR is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
PHR vs FORA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas FORA's P/E ratio is -24.11. In terms of profitability, PHR's ROE is +0.03%, compared to FORA's ROE of -0.17%. Regarding short-term risk, PHR is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
PHR vs CCLDP Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CCLDP's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
PHR vs ONMD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ONMD has a market cap of 39.2M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ONMD trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ONMD's P/E ratio is -4.30. In terms of profitability, PHR's ROE is +0.03%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, PHR is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
PHR vs SNCE Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SNCE's P/E ratio is -0.27. In terms of profitability, PHR's ROE is +0.03%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, PHR is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
PHR vs AKLI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas AKLI's P/E ratio is -0.71. In terms of profitability, PHR's ROE is +0.03%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, PHR is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
PHR vs SHLT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SHLT's P/E ratio is -3.87. In terms of profitability, PHR's ROE is +0.03%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, PHR is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
PHR vs SHCRW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, PHR is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
PHR vs ONMDW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ONMDW has a market cap of 26.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ONMDW's P/E ratio is -0.19. In terms of profitability, PHR's ROE is +0.03%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, PHR is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
PHR vs STRM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas STRM's P/E ratio is -2.40. In terms of profitability, PHR's ROE is +0.03%, compared to STRM's ROE of -0.65%. Regarding short-term risk, PHR is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
PHR vs RNLX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas RNLX's P/E ratio is -0.33. In terms of profitability, PHR's ROE is +0.03%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, PHR is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
PHR vs LIFW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas LIFW's P/E ratio is -0.02. In terms of profitability, PHR's ROE is +0.03%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
PHR vs BBLN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas BBLN's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, PHR is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
PHR vs ETAO Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ETAO's P/E ratio is -0.01. In terms of profitability, PHR's ROE is +0.03%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, PHR is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
PHR vs BFRG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, BFRG has a market cap of 9.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while BFRG trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas BFRG's P/E ratio is -1.07. In terms of profitability, PHR's ROE is +0.03%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, PHR is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BFRG's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
PHR vs MGRX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MGRX has a market cap of 7.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MGRX trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MGRX's P/E ratio is -0.33. In terms of profitability, PHR's ROE is +0.03%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, PHR is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
PHR vs UPH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas UPH's P/E ratio is -0.07. In terms of profitability, PHR's ROE is +0.03%, compared to UPH's ROE of -1.05%. Regarding short-term risk, PHR is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
PHR vs UPH-WT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, PHR is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
PHR vs PEAR Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas PEAR's P/E ratio is -0.08. In terms of profitability, PHR's ROE is +0.03%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for PHR.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
PHR vs PEARW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas PEARW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
PHR vs OTRK Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas OTRK's P/E ratio is -0.02. In terms of profitability, PHR's ROE is +0.03%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, PHR is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
PHR vs CMAX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CMAX's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, PHR is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
PHR vs ACON Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ACON trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ACON's P/E ratio is -0.27. In terms of profitability, PHR's ROE is +0.03%, compared to ACON's ROE of -0.59%. Regarding short-term risk, PHR is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
PHR vs LIFWZ Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFWZ's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
PHR vs BFRGW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, BFRGW has a market cap of 1.1M. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while BFRGW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas BFRGW's P/E ratio is -0.19. In terms of profitability, PHR's ROE is +0.03%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, PHR is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BFRGW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
PHR vs HCTI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, HCTI has a market cap of 901.5K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while HCTI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas HCTI's P/E ratio is -0.10. In terms of profitability, PHR's ROE is +0.03%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, PHR is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for PHR.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
PHR vs VSEEW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, PHR is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
PHR vs MSPRZ Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, PHR is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
PHR vs VSEE Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, VSEE has a market cap of 273.2K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while VSEE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas VSEE's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, PHR is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for PHR.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERNW)
PHR vs KERNW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas KERNW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, PHR is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
PHR vs KERN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas KERN's P/E ratio is -0.01. In terms of profitability, PHR's ROE is +0.03%, compared to KERN's ROE of -0.20%. Regarding short-term risk, PHR is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
PHR vs LIFWW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas LIFWW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
PHR vs CMAXW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CMAXW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, PHR is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
PHR vs ZCMD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ZCMD has a market cap of 27.5K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ZCMD trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, PHR's ROE is +0.03%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, PHR is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
PHR vs ACONW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, ACONW has a market cap of 14.9K. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas ACONW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, PHR is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ACONW's competition here
Castlight Health, Inc. (NYSE: CSLT)
PHR vs CSLT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CSLT's P/E ratio is -37.27. In terms of profitability, PHR's ROE is +0.03%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, PHR is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CSLT's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
PHR vs CHNG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CHNG's P/E ratio is -152.72. In terms of profitability, PHR's ROE is +0.03%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, PHR is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CHNG's competition here
Cerner Corporation (NASDAQ: CERN)
PHR vs CERN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CERN has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CERN's P/E ratio is 55.84. In terms of profitability, PHR's ROE is +0.03%, compared to CERN's ROE of +0.14%. Regarding short-term risk, PHR is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CERN's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
PHR vs CNVY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CNVY's P/E ratio is -71.50. In terms of profitability, PHR's ROE is +0.03%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, PHR is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CNVY's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
PHR vs IMS Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, IMS has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas IMS's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to IMS's ROE of +0.27%. Regarding short-term risk, PHR is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for PHR.Check IMS's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
PHR vs NAVA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas NAVA's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, PHR is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for PHR.Check NAVA's competition here
CareCloud, Inc. (NASDAQ: MTBC)
PHR vs MTBC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MTBC's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, PHR is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
PHR vs MTBCO Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MTBCO's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MTBCO's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
PHR vs CHNGU Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas CHNGU's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, PHR is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CHNGU's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
PHR vs AFFX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas AFFX's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AFFX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
PHR vs MSPRV Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MSPRV's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MSPRV's ROE of N/A. Regarding short-term risk, PHR is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MSPRV's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
PHR vs KURIU Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas KURIU's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, PHR is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KURIU's competition here
NantHealth, Inc. (NASDAQ: NH)
PHR vs NH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, NH has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas NH's P/E ratio is -0.12. In terms of profitability, PHR's ROE is +0.03%, compared to NH's ROE of +0.35%. Regarding short-term risk, PHR is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check NH's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
PHR vs MTBCP Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas MTBCP's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MTBCP's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
PHR vs SMFRW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 620M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, PHR is priced at $10.10 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 35.82, whereas SMFRW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SMFRW's competition here